聚焦颌骨坏死诊疗挑战:迈向精准治疗策略
颌骨坏死(ONJ)主要包括放射性颌骨坏死(ORNJ)和药物相关性颌骨坏死(MRONJ),随头颈肿瘤综合治疗水平提高及抗骨吸收药物、抗血管生成药物广泛应用,其临床发生率呈逐渐上升趋势。该病常表现为骨组织暴露、慢性感染、颌骨破坏及功能障碍,严重影响患者生活质量并给临床诊疗带来巨大挑战。本文结合国内外研究进展,从临床挑战、诊疗突破及未来发展方向进行探讨,旨在为完善ONJ诊疗理念提供参考。
要点
- ONJ主要包括ORNJ和MRONJ,临床发生率呈逐渐上升趋势。
- ONJ常表现为骨组织暴露、慢性感染、颌骨破坏及功能障碍。
- 精准医学、数字化外科及再生医学为ONJ治疗提供新思路。
核心结论
- ONJ临床诊疗水平已显著提升,精准医学、数字化外科及再生医学为治疗提供新思路和路径。
研究设计与样本
- 本文为结合近年来国内外研究进展的专题论述,围绕ONJ临床挑战、诊疗突破及未来发展方向进行探讨。
主要发现
- ONJ主要包括ORNJ及MRONJ,随头颈肿瘤综合治疗水平提高及抗骨吸收药物、抗血管生成药物临床应用日益广泛,临床发生率呈逐渐上升趋势。
- ONJ常表现为骨组织暴露、慢性感染、颌骨破坏及功能障碍,严重影响患者生活质量并给临床诊疗带来巨大挑战。
- 近年来对ONJ发病机制认识不断深入、分类分期体系逐步建立及规范化诊疗共识发布,使ONJ临床诊疗水平显著提升。
临床怎么用
- 临床应关注ONJ发生率上升趋势,重视骨组织暴露、慢性感染、颌骨破坏及功能障碍等表现。
- 可结合精准医学、数字化外科及再生医学等新技术优化ONJ诊疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteonecrosis of the jaw (ONJ) is one of the most challenging diseases in the field of oral and maxillofacial surgery, mainly including osteoradionecrosis of the jaw (ORNJ) and medication-related osteonecrosis of the jaw (MRONJ). With the continuous improvement in comprehensive treatment strategies for head and neck malignancies and the increasingly widespread clinical use of antiresorptive agents and antiangiogenic drugs, the incidence of ONJ has shown a gradual upward trend. Clinically, the disease is commonly characterized by exposed necrotic bone, chronic infection, progressive destruction of the jawbone, and functional impairment, which not only severely compromises patients' quality of life but also poses substantial challenges to clinical management. In recent years, significant progress has been achieved in the understanding of the pathogenesis of ONJ, the establishment of classification and staging systems, and the development of consensus guidelines for standardized diagnosis and treatment, leading to notable improvements in clinical management. Meanwhile, advances in precision medicine, digital surgery, and regenerative medicine have provided new perspectives and therapeutic strategies for the management of ONJ. Based on recent domestic and international research progress, this article discusses the clinical challenges, advances in diagnosis and treatment, and future development directions of ONJ, aiming to provide insights for further improving diagnostic and therapeutic strategies and promoting continued research in this field. 颌骨坏死(ONJ)是口腔颌面外科领域颇具挑战性的疾病之一,主要包括放射性颌骨坏死(ORNJ)及药物相关性颌骨坏死(MRONJ)。随着头颈肿瘤综合治疗水平的不断提高,以及抗骨吸收药物、抗血管生成药物等临床应用的日益广泛,ONJ的临床发生率呈逐渐上升趋势。该疾病常表现为骨组织暴露、慢性感染、颌骨破坏及功能障碍,不仅严重影响患者生活质量,也给临床诊疗带来巨大挑战。近年来,随着对发病机制认识的不断深入、分类分期体系的逐步建立及规范化诊疗共识的发布,ONJ临床诊疗水平显著提升。同时,精准医学、数字化外科及再生医学等新技术的发展,为ONJ的治疗提供了新的思路和路径。本文结合近年来国内外研究进展,从临床挑战、诊疗突破及未来发展方向等方面进行探讨,旨在为推动ONJ诊疗理念的完善及相关研究的深入提供参考与思考。.
引用
- He Y. [Focusing on the challenges in the diagnosis and treatment of osteonecrosis of the jaw: toward precision therapeutic strategies]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2026. PMID: 42532523. doi:10.3760/cma.j.cn112144-20260401-00206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。